Top

Clinical and Translational Oncology

Published in:

01-03-2011 | Educational Series

New technologies in cancer. Protein microarrays for biomarker discovery

Authors: Sergio Matarraz, María González-González, María Jara, Alberto Orfao, Manuel Fuentes

Published in: Clinical and Translational Oncology | Issue 3/2011

Title: New technologies in cancer. Protein microarrays for biomarker discovery
Authors: Sergio Matarraz
María González-González
María Jara
Alberto Orfao
Manuel Fuentes
Publication date: 01-03-2011
Publisher: Springer Milan
Published in: Clinical and Translational Oncology / Issue 3/2011
Print ISSN: 1699-048X
Electronic ISSN: 1699-3055
DOI: https://doi.org/10.1007/s12094-011-0635-8

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Please log in to get access to this content

Other articles of this Issue 3/2011

Prognostic factors in desmoid tumours: an example of translational oncology

Treatment recommendations for metastatic colorectal cancer

Mechanism of hot flashes

Direct antitumour activity of zoledronic acid: preclinical and clinical data

Phase II study of trastuzumab and cisplatin as first-line therapy in patients with HER2-positive advanced gastric or gastroesophageal junction cancer

Circulating tumour cells in peripheral blood: potential impact on breast cancer outcome

Keynote webinar | Spotlight on antibody–drug conjugates in cancer